Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Donna L Forrest

Showing results (1-10 of 44) with videos related to

Pageof 5
Sort By:
Cancer|November 30, 2006
Second solid cancers after allogeneic hematopoietic stem cell transplantationGenevieve Gallagher, Donna L Forrest
Cancer Genetics and Cytogenetics|January 28, 2003
Constitutional rearrangements of 7q22 in hematologic malignancies. a new case reportDonna L Forrest, Christine L Y Lee
Cancer Genetics and Cytogenetics|February 12, 2008
Fusion of PRKG2 and SPTBN1 to the platelet-derived growth factor receptor beta gene (PDGFRB) in imatinib-responsive atypical myeloproliferative disordersGenevieve Gallagher, Douglas E Horsman, Peter Tsang, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 4, 2008
Serotonin syndrome after concomitant treatment with linezolid and meperidinePrabodh K Das, Dawn I Warkentin, Robert Hewko, et al.
American Journal of Hematology|November 30, 2006
Imatinib mesylate responsiveness in aggressive systemic mastocytosis: novel association with a platelet derived growth factor receptor beta mutationBakul I Dalal, Douglas E Horsman, Hélène Bruyèrè, et al.
Cells|October 15, 2025
Dual Targeting of Smoothened, a Key Regulator in the Hedgehog Pathway, and BCR-ABL1 Effectively Eradicates Drug-Insensitive Stem/Progenitor Cells in Chronic Myeloid LeukemiaKelly A Turner, Min Chen, Katharina Rothe, et al.
International Journal of Molecular Sciences|July 12, 2025
Identification of a PAK6-Mediated MDM2/p21 Axis That Modulates Survival and Cell Cycle Control of Drug-Resistant Stem/Progenitor Cells in Chronic Myeloid LeukemiaAndrew Wu, Min Chen, Athena Phoa, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 4, 2003
Renal pathology at autopsy in patients who died after hematopoietic stem cell transplantationSomaya El-Seisi, Rekha Gupta, Catherine M Clase, et al.
Leukemia Research|April 26, 2011
Disseminated mucormycosis presenting as transplant-associated thrombotic microangiopathyErica A Peterson, Alina S Gerrie, Maryse M Power, et al.
Leukemia|October 17, 2023
Identification of multivariable microRNA and clinical biomarker panels to predict imatinib response in chronic myeloid leukemia at diagnosisAndrew Wu, Ryan Yen, Sarah Grasedieck, et al.
Pageof 5

Showing results (1-10 of 44) with videos related to

Sort By:
Pageof 5
Cancer|November 30, 2006
Second solid cancers after allogeneic hematopoietic stem cell transplantationGenevieve Gallagher, Donna L Forrest
Cancer Genetics and Cytogenetics|January 28, 2003
Constitutional rearrangements of 7q22 in hematologic malignancies. a new case reportDonna L Forrest, Christine L Y Lee
Cancer Genetics and Cytogenetics|February 12, 2008
Fusion of PRKG2 and SPTBN1 to the platelet-derived growth factor receptor beta gene (PDGFRB) in imatinib-responsive atypical myeloproliferative disordersGenevieve Gallagher, Douglas E Horsman, Peter Tsang, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 4, 2008
Serotonin syndrome after concomitant treatment with linezolid and meperidinePrabodh K Das, Dawn I Warkentin, Robert Hewko, et al.
American Journal of Hematology|November 30, 2006
Imatinib mesylate responsiveness in aggressive systemic mastocytosis: novel association with a platelet derived growth factor receptor beta mutationBakul I Dalal, Douglas E Horsman, Hélène Bruyèrè, et al.
Cells|October 15, 2025
Dual Targeting of Smoothened, a Key Regulator in the Hedgehog Pathway, and BCR-ABL1 Effectively Eradicates Drug-Insensitive Stem/Progenitor Cells in Chronic Myeloid LeukemiaKelly A Turner, Min Chen, Katharina Rothe, et al.
International Journal of Molecular Sciences|July 12, 2025
Identification of a PAK6-Mediated MDM2/p21 Axis That Modulates Survival and Cell Cycle Control of Drug-Resistant Stem/Progenitor Cells in Chronic Myeloid LeukemiaAndrew Wu, Min Chen, Athena Phoa, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 4, 2003
Renal pathology at autopsy in patients who died after hematopoietic stem cell transplantationSomaya El-Seisi, Rekha Gupta, Catherine M Clase, et al.
Leukemia Research|April 26, 2011
Disseminated mucormycosis presenting as transplant-associated thrombotic microangiopathyErica A Peterson, Alina S Gerrie, Maryse M Power, et al.
Leukemia|October 17, 2023
Identification of multivariable microRNA and clinical biomarker panels to predict imatinib response in chronic myeloid leukemia at diagnosisAndrew Wu, Ryan Yen, Sarah Grasedieck, et al.
Pageof 5